what are glp-1 agonists Receptor and Research to Treat Overeating and Substance Use Disorders Current Insights, Advantages and Challenges
Description
In T2DM, agents such as semaglutide and tirzepatide effectively lower HbA1c levels, blood glucose levels, and body weight, outperforming conventional oral hypoglycemic agents and insulin
A mechanistic rationale for incretin-based therapeutics in the management of obesity
Clinical implication Clinicians are encouraged to perform comprehensive evaluations prior to prescribing GLP-1 RA therapy in patients with a history of pancreatic disorders or other pancreatitis risk factors
Ethics declarations Competing Interests The authors declare no competing interests
Our program allows you to use real GLP-1 medications (not compounded), and takes advantage of inefficiencies in our medication pricing system
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
